Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05239026 · ClinicalTrials.gov registry record · NA

Treadmill Training in People With Parkinson's Disease

A NA study of Parkinson Disease, sponsored by Georgia State University.

Completed
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT05239026 is a NA study of Parkinson Disease that has completed, run by Georgia State University. The registered enrollment target is 32 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05239026, a NA study of Parkinson Disease, has completed, sponsored by Georgia State University.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

The study will explore if coupling speed and cadence during treadmill training elicit more benefits than controlling speed alone in individuals with Parkinson's disease.

Conditions Studied

Interventions

  • BEHAVIORAL Advanced treadmill walking
  • BEHAVIORAL Traditional treadmill walking

Study Locations (1)

Georgia

  • Georgia State University - Atlanta

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2022-03-21
Est. Completion 2024-07-09
Phase NA

Sponsor

Georgia State University

45 total trials

What the Registry Record Tells You About NCT05239026

The ClinicalTrials.gov registry entry for NCT05239026 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The listed sponsor is Georgia State University, which has 45 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 2 interventions - of which Advanced treadmill walking is the first listed.

NCT05239026 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT05239026 about?

NCT05239026 is a clinical study titled "Treadmill Training in People With Parkinson's Disease". The study will explore if coupling speed and cadence during treadmill training elicit more benefits than controlling speed alone in individuals with Parkinson's disease.

What is the current status of trial NCT05239026?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2022-03-21. Estimated completion is 2024-07-09.

What conditions does trial NCT05239026 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT05239026?

The interventions under investigation include: Advanced treadmill walking (BEHAVIORAL), Traditional treadmill walking (BEHAVIORAL).

Who is sponsoring clinical trial NCT05239026?

This trial is sponsored by Georgia State University, which has 45 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05239026 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.